• Home
  • Who we are
  • Pipeline
  • News
  • Contact
ORPHELIA Pharma
  • Orphelia pharma
    ORPHELIA Pharma is a biopharmaceutical company dedicated to the development and marketing of pediatric and orphan drugs.
  • Orphelia pharma
    Our mission is to develop essential medicines to improve
    care and support of patients suffering from orphan diseases.

Latest news and reports

Latest news and report

  • 2 February 2021

    Opening of the operating pharmaceutical establishment


    Read more
  • 26 January 2021

    Grant obtained from the region Île-de-France to support business activity development in Europe and the United States


    Read more
  • 19 January 2021

    Signature of a licensing agreement for the development and marketing of Kigabeq® in China


    Read more
  • 12 October 2020

    ORPHELIA Pharma to organize a Symposium at the SIOP congress 2020


    Read more
  • 5 October 2020

    Inclusion of the first patient in a clinical study evaluating Kimozo


    Read more
  • 1 October 2020

    Meet us at BIO-Europe 2020, October 26-29


    Read more
  • 14 September 2020

    ORPHELIA Pharma will attend and support the annual SIOP Congress 2020


    Read more
  • 11 March 2020

    ORPHELIA announces the appointment of Laurent Martin as Chief Pharmaceutical Affairs Officer


    Read more

ORPHELIA Pharma - 85 boulevard Saint Michel, 75005 Paris
+ 33 (0)1 42 77 08 18 - contact@orphelia-pharma.eu